FUJIFILM Biotechnologies has announced that it will be attending this year's CPHI show in Milan, with nominations shortlisted for three CPHI Pharma Awards.
The CDMO has been shortlisted for the following awards:
- Woman of the Year: Maja Pedersen, President & Chief Operating Officer
- Innovation Catalyst: MaruX Continuous Manufacturing Platform
- API Development and Innovation: ShunzymeX Precision Purification Technology
“At CPHI, I look forward to hearing directly from our partners about what they need to move their programmes forward,” said Maja Pedersen, President and Chief Operating Officer of FUJIFILM Biotechnologies.
Our expanding global manufacturing network gives us more ways to support them. Our focus is on making that network work as one: kojoX. Bringing new capacity online, delivering reliably and giving partners the visibility they need to plan with confidence.
The firm will bring its senior leadership team for partnering meetings, networking and a series of speaking sessions, with the speaker lineup featuring the following:
- Christiane Bardroff, Chief Business Officer : Pharma’s Structural Shift: What’s Reshaping Global Priorities , October 6,10:55-11:50 AM CEST
- Christian Houborg, General Manager & Senior Vice President, FUJIFILM Biotechnologies Denmark: Beyond the Blueprint: Executing Europe’s Bio-Manufacturing Vision , October 7, 11:35 AM-12:20 PM CEST
- Jonathan Haigh, Senior Vice President & UK Site Head, FUJIFILM Biotechnologies: Building a BsAb CMC Playbook: Decision Frameworks, Risks and Readiness, October 7, 1:45-2:10 PM CEST
Attendees can meet with Fujifilm at CPHI 2026 in Milan at Booth #8A2.
